These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30153954)

  • 41. Sympathetic ganglionectomy for facial blushing using application of laser speckle flow graph.
    Yamamoto H; Okada M
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1326-1331. PubMed ID: 29525260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereoselective synthesis of desloratadine derivatives as antagonist of histamine.
    Liu GZ; Xu HW; Chen GW; Wang P; Wang YN; Liu HM; Yu DQ
    Bioorg Med Chem; 2010 Feb; 18(4):1626-32. PubMed ID: 20110173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus placebo in suppressing the cutaneous response to histamine.
    Grant JA; Danielson L; Rihoux J; DeVos C
    Int Arch Allergy Immunol; 1999; 118(2-4):339-40. PubMed ID: 10224437
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of niacin on facial blood flow in people with an elevated fear of negative evaluation.
    Drummond PD; Lazaroo D
    Eur Neuropsychopharmacol; 2012 Mar; 22(3):200-4. PubMed ID: 21856131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin.
    Purohit A; Melac M; Pauli G; Frossard N
    Br J Clin Pharmacol; 2003 Oct; 56(4):388-94. PubMed ID: 12968983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio.
    Kubo N; Senda M; Ohsumi Y; Sakamoto S; Matsumoto K; Tashiro M; Okamura N; Yanai K
    Hum Psychopharmacol; 2011 Mar; 26(2):133-9. PubMed ID: 21433074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of loratadine, a histamine H
    Folwarczna J; Konarek N; Freier K; Karbowniczek D; Londzin P; Janas A
    Drug Des Devel Ther; 2019; 13():3357-3367. PubMed ID: 31576110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
    Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
    Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
    Roongapinun S; Wajajamreon S; Fooanant S
    J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection against histamine-induced bronchoconstriction by loratadine.
    Debelić M
    Allergol Immunopathol (Madr); 1992; 20(3):97-100. PubMed ID: 1357946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physico-chemical characterization and in vitro/in vivo evaluation of loratadine:dimethyl-β-cyclodextrin inclusion complexes.
    Szabados-Nacsa A; Sipos P; Martinek T; Mándity I; Blazsó G; Balogh Á; Szabó-Révész P; Aigner Z
    J Pharm Biomed Anal; 2011 May; 55(2):294-300. PubMed ID: 21316895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
    Carey W; Warrington S; Boyce M; Luria X
    Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blushing during social interactions in people with a fear of blushing.
    Drummond PD; Back K; Harrison J; Helgadottir FD; Lange B; Lee C; Leavy K; Novatscou C; Orner A; Pham H; Prance J; Radford D; Wheatley L
    Behav Res Ther; 2007 Jul; 45(7):1601-8. PubMed ID: 16890188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on performance and sleepiness with the H1-antihistamine, desloratadine.
    Nicholson AN; Handford AD; Turner C; Stone BM
    Aviat Space Environ Med; 2003 Aug; 74(8):809-15. PubMed ID: 12924753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. H1 but not H2 histamine receptor activation contributes to the rise in skin blood flow during whole body heating in humans.
    Wong BJ; Wilkins BW; Minson CT
    J Physiol; 2004 Nov; 560(Pt 3):941-8. PubMed ID: 15375193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH; Briscoe M; Widlitz MD
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiological blushing in social anxiety disorder patients with and without blushing complaints: two subtypes?
    Voncken MJ; Bögels SM
    Biol Psychol; 2009 May; 81(2):86-94. PubMed ID: 19428972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maximum skin hyperaemia induced by local heating: possible mechanisms.
    Gooding KM; Hannemann MM; Tooke JE; Clough GF; Shore AC
    J Vasc Res; 2006; 43(3):270-7. PubMed ID: 16498265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
    Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
    Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.